Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,232,158 papers from all fields of science
Search
Sign In
Create Free Account
ethyl loflazepate
Known as:
1H-1,4-benzodiazepine-3-carboxylic acid, 7-chloro-5-(2-fluorophenyl)-2,3-dihydro-2-oxo-, ethyl ester
, ethyl flucozepate
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (2)
Anti-Anxiety Agents
Benzodiazepines
Narrower (2)
Meilax
Victan
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Specific and sensitive analysis of nefopam and its main metabolite desmethyl-nefopam in human plasma by liquid chromatography-ion trap tandem mass spectrometry.
G. Hoizey
,
Anne Goglin
,
+5 authors
D. Lamiable
Journal of Pharmaceutical and Biomedical Analysis
2006
Corpus ID: 35325763
2006
2006
Efficacy of ethyl loflazepate for phantogeusia-a case study
H. Takahashi
,
A. Toyofuku
,
Nao Ikeyama
,
M. Saiki
,
A. Matsunaga
,
T. Kikuta
2006
Corpus ID: 58083460
The condition of having a normal physical sense of taste but finding flavors strange and unpleasant is known as phantogeusia and…
Expand
1992
1992
Acute poisonings with ethyle loflazepate, flunitrazepam, prazepam and triazolam in children.
C. Pulce
,
P. Mollon
,
E. Pham
,
P. Frantz
,
J. Descotes
Veterinary and human toxicology
1992
Corpus ID: 24126562
Even though acute poisonings with benzodiazepines are extremely common, less is known of the clinical toxicity of recent…
Expand
1988
1988
Effects of ethyl loflazepate (CM 6912) on sleep in normal humans.
Y. Mizuki
,
H. Kuwahara
,
H. Isozaki
,
M. Tanaka
,
K. Inanaga
Methods and Findings in Experimental and Clinical…
1988
Corpus ID: 44607055
The effects of 2 mg and 4 mg of ethyl loflazepate (CM 6912), a new anxiolytic benzodiazepine, on sleep were studied in 12 healthy…
Expand
1985
1985
Inhibitory effect on 3H-diazepam binding and potentiating action on GABA of ethyl loflazepate, a new minor tranquilizer.
Y. Sakai
,
M. Namima
Japanese Journal of Pharmacology
1985
Corpus ID: 24241411
A new benzodiazepine compound, ethyl loflazepate (ethyl-7-chloro-2,3-dihydro-5-(2-fluorophenyl)-2-oxo-1H,1,4- benzodiazepine-3…
Expand
1985
1985
Metabolism of ethyl loflazepate in the rat, the dog, the baboon and in man.
H. Davi
,
J. Guyonnet
,
Y. Sales
,
W. Cautreels
Arzneimittel-Forschung
1985
Corpus ID: 35804477
The metabolism of ethyl loflazepate (Victan), a new benzodiazepine used as an anxiolytic drug, was studied in man and several…
Expand
1985
1985
Evaluation of EMIT-TOX Enzyme Immunoassay for the analysis of benzodiazepines in serum: usefulness and limitations in an emergency laboratory.
M. Manchon
,
M. F. Verdier
,
P. Pallud
,
A. Vialle
,
F. Beseme
,
J. Bienvenu
Journal of Analytical Toxicology
1985
Corpus ID: 9401180
The EMIT-TOX Enzyme Immunoassay for benzodiazepines was evaluated. Reproducibility, linearity, accuracy, sensitivity, and…
Expand
1985
1985
Antianxiety Effect of Ehtyl Loflazepate, CM6912, Assessed by Frontal Medline Theta Activity in Man
Y. Mizuki
,
H. Hirano
,
+4 authors
K. Inanaga
1985
Corpus ID: 68833418
1984
1984
Studies on the muscle relaxation effects of ethyl loflazepate (CM6912) and evaluation as an anti-anxiety drug.
Y. Sakai
,
M. Namima
Japanese Journal of Pharmacology
1984
Corpus ID: 9604541
A new anti-anxiety drug, CM6912 (ethyl loflazepate, ethyl 7-chloro-2,3-dihydro-5-(2-fluorophenyl)-2-oxo-1H-1,4-benzodiazepine-3…
Expand
1980
1980
Quantitative analysis of CM 6912 (ethyl loflazepate) and its metabolites in plasma and urine by chemical ionization gas chromatography mass spectrometry. Application to pharmacokinetic studies in man…
W. Cautreels
,
J. P. Jeanniot
Biomedical mass spectrometry
1980
Corpus ID: 45660002
A chemical ionization gas chromatographic mass spectrometric assay is described for ethyl loflazepate (CM 6912), a new…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE